Circadian Regulation of Drug Responses: Toward Sex-Specific and Personalized Chronotherapy.

Lévi, Francis A; Okyar, Alper; Hadadi, Eva; Innominato, Pasquale F; Ballesta, Annabelle

Lévi, Francis A; Okyar, Alper; Hadadi, Eva; Innominato, Pasquale F; Ballesta, Annabelle.

Afiliação

Lévi FA; Chronotherapy, Cancers and Transplantation Research Unit, Faculty of Medicine, Paris-Saclay University, Villejuif, France; email: francis.levi@universite-paris-saclay.fr.
Okyar A; Gastrointestinal and General Oncology Service, Paul-Brousse Hospital, Assistance Publique-Hôpitaux de Paris, Villejuif, France.
Hadadi E; Department of Statistics, University of Warwick, Coventry, United Kingdom.
Innominato PF; Faculty of Pharmacy, Department of Pharmacology, Istanbul University, Beyazit-Istanbul, Turkey.
Ballesta A; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium.

Annu Rev Pharmacol Toxicol ; 64: 89-114, 2024 Jan 23.

Article em En | MEDLINE | ID: mdl-37722720

Assuntos

Relógios Circadianos; Neoplasias; Masculino; Feminino; Humanos; Ritmo Circadiano; Cronoterapia; Neoplasias/tratamento farmacológico; Preparações Farmacêuticas

Palavras-chave

between-subjects variability; chronopharmacology; chronotherapy; circadian rhythms; precision medicine; sex specificity

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Relógios Circadianos / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Annu Rev Pharmacol Toxicol Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google